💊 Medicine AT September 8, 2026

Nimvastid 1,5 mg Hartkapseln 1,5 mg (Hartkapsel)

📷 Wikipedia: Rivastigmine · Source

ATC: N06DA03
Reason: Verzögerung bei der Herstellung
Marketing authorisation holder: KRKA d.d. Novo Mesto, Smarjeska Cesta 6, 8501 Novo Mesto, Slowenien
Affected packs: 60 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-08, resupply 2026-10-31]

⚠️

Shortage ongoing

RIVASTIGMIN is currently in short supply in AT.

📈 Timeline

2 days active so far

September 9, 2026 September 10, 2026

A plain-language summary will appear here shortly. Read the official notice below.

🔬 Medical / technical details (for professionals)

Active substance(s)

RIVASTIGMIN

Agency-published detail

ATC: N06DA03 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: KRKA d.d. Novo Mesto, Smarjeska Cesta 6, 8501 Novo Mesto, Slowenien · Affected packs: 60 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-08, resupply 2026-10-31] · 30 Stück Schachtel, Blisterpackung [verfügbar]

First published

September 8, 2026

Last refreshed by us

14 hours ago

Severity (as classified)

High

Official source

https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

🔔 Stay informed

Get an email if there's an update.

Free · One click to unsubscribe

📤 Tell someone

🦋 Bluesky 𝕏 🐘 💬 WhatsApp ✈️ Telegram ✉️ Email

📋 Quick facts

Status

Shortage ongoing

Affects

First detected by us

September 9, 2026

Agency-reported start

September 8, 2026

Days active

Related alerts

High AT 2 days ago

Nimvastid 6 mg Hartkapseln 6 mg (Hartkapsel)

Low AT resolved 3 months ago

Rivastigmin 1A Pharma 13,3 mg/24 Stunden - transdermales Pflaster 13,3 mg/24 h mg/24 h (transdermales Pflaster)

Rivastigmine 1A Pharma 13.3 mg/24 hours – transdermal patch 13.3 mg/24 hours (transdermal patch) Parallel export ban in effect.

Medium AT resolved 3 months ago

Nimvastid 3 mg Hartkapseln 3 mg (Hartkapsel)

Nimvastid 3 mg hard capsules are delayed. Affected packs are the 60-count blister box. Supply is unavailable since 3 June 2026 and expected to resume on 31 July 2026.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?

Nimvastid 1,5 mg Hartkapseln 1,5 mg (Hartkapsel). ATC: N06DA03 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: KRKA d.d. Novo Mesto, Smarjeska Cesta 6, 8501 Novo Mesto, Slowenien · Affected packs: 60 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-09-08, resupply 2026-10-31] · 30 Stück Sc...

▸ When was this alert issued?

This alert was issued on September 8, 2026 by BASG (Austria).

▸ Which countries are affected?

The alert applies to Austria.

▸ How serious is this alert?

Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.

▸ What should I do?

If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.

▸ Where can I find the official notice?

The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.